Manisha Thapliyal | Bioinformatics | Best Researcher Award

Published on 02/04/2025 by Neuroscientists

Ms. Manisha Thapliyal | Bioinformatics | Best Researcher Award

Ms. Manisha Thapliyal, Patanjali Research Foundation, India.

Manisha Thapliyal is a dedicated scientist with six years of experience in biotechnology, bioinformatics, and computational drug design. She has led research teams, contributed to groundbreaking studies, and played a key role in developing novel therapeutic solutions. With expertise in plant genetic transformation, nanoparticle synthesis, and large-scale research projects, she is committed to advancing scientific innovation. Her passion for mentoring and organizing scientific events underscores her commitment to fostering future research talent.

Profile

Google Scholar

🌱 Early Academic Pursuits

Manisha Thapliyal’s journey into the world of scientific exploration began with a strong foundation in biotechnology and bioinformatics. Driven by an innate curiosity for life sciences, she pursued higher education with a focus on cutting-edge research methodologies. Her academic endeavors laid the groundwork for her specialization in computational drug design, plant genetic transformation, and nanotechnology. From her early years, she exhibited a passion for interdisciplinary studies, which later became a defining aspect of her professional career.

🧬 Professional Endeavors

With six years of experience in scientific research, Manisha Thapliyal has excelled in leading and managing research teams at the Patanjali Research Foundation in Haridwar. As a Scientist-B, she has guided Assistant Scientists in Computer-Aided Drug Designing (CADD), playing a pivotal role in developing potential therapeutic solutions. Her ability to seamlessly collaborate with bench scientists has ensured that computational strategies align with practical laboratory objectives. Through virtual screenings and molecular analyses, she has significantly contributed to identifying novel drug candidates with promising pharmacological potential.

🔬 Contributions and Research Focus

Manisha’s expertise extends across multiple domains, including plant genetic transformation studies, nanoparticle synthesis, and large-scale government-funded research projects. Her interdisciplinary approach bridges computational and experimental research, facilitating innovation in biotechnology. Her technical prowess in bioinformatics has enabled her to decode complex biological datasets, opening new avenues for scientific breakthroughs. Her research contributions are not limited to publications but extend to mentoring young scientists and fostering research-driven environments.

🏆 Accolades and Recognition

Recognized for her dedication and innovation in scientific research, Manisha has played a crucial role in several high-impact studies and book chapters. Her ability to integrate computational tools with experimental frameworks has earned her acclaim within the research community. She has been instrumental in organizing national and international conferences, workshops, and training programs, further solidifying her role as a thought leader in the field of biotechnology

🌍 Impact and Influence

Beyond her technical contributions, Manisha has been an active mentor, shaping the careers of aspiring researchers and young scientists. Her leadership in capacity-building initiatives has empowered the next generation of scientists to develop skills in drug discovery, genetic engineering, and bioinformatics. By fostering collaborative research environments, she has ensured that scientific advancements translate into meaningful healthcare and biotechnological solutions.

🔮 Legacy and Future Contributions

With an unwavering commitment to scientific excellence, Manisha Thapliyal envisions a future where biotechnology continues to drive innovation in medicine and environmental sustainability. Her focus remains on leveraging computational intelligence for precision drug discovery and sustainable biotechnological applications. As she advances in her career, she aims to expand her research horizon, bridging the gap between theoretical insights and real-world applications, ultimately contributing to the global scientific community.

Publication

SCREENING AND ISOLATION OF ANTIBACTERIAL PROTEINS/PEPTIDES FROM SEEDS OF MILLETS
Authors: Anjali Bisht, Manisha Thapliyal
Year: 2016

ISOLATION OF ANTIBACTERIAL PROTEIN/PEPTIDE FROM FICUS GLOMERATA LEAF
Authors: Manisha Thapliyal, Anjali Bisht
Year: 2016

Current Status of Indian Agriculture: Problems, Challenges and Solution
Authors: Acharya Balkrishna, Manisha Phour
Year: 2021

Role of AP2/EREBP Transcription Factor Family in Environmental Stress Tolerance
Authors: Anjali Pande, Saurabh C Saxena, Manisha Thapliyal, Sudhir K Guru, Atul Kumar
Year: 2018

Unraveling the therapeutic potential of Senna singueana phytochemicals to attenuate pancreatic cancer using protein–protein interactions, molecular docking, and …
Authors: Acharya Balkrishna, D Sharma, M Thapliyal, V Arya, A Dabas
Year: 2023

Isolation and Identification of α- Amylase activity Inhibiting compounds from Bryophyllum Pinnatum
Authors: S R Kumar, M Thapliyal, A Singh
Year: 2016

🏁 Conclusion

Manisha Thapliyal stands as a beacon of inspiration in the ever-evolving field of biotechnology. Her relentless pursuit of scientific excellence, coupled with her leadership in research and mentorship, has positioned her as a key contributor to scientific progress. Through her continued efforts in biotechnology and bioinformatics, she is set to make lasting contributions that will shape the future of drug discovery and sustainable scientific solutions.

Vikash Kumar | Molecular Biology | Best Researcher Award

Published on 05/03/202507/03/2025 by Neuroscientists

Dr. Vikash Kumar | Molecular Biology | Best Researcher Award

Dr. Vikash Kumar, Central Inland Fisheries Research Institute, India.

Dr. Vikash Kumar is a distinguished scientist in the field of aquaculture and fish health management, with over 15 years of research experience. His academic journey, from earning a Ph.D. with distinction at Ghent University to holding key research positions at ICAR-CIFRI, has been marked by excellence. His expertise spans transcriptomics, proteomics, cellular biology, and immunohistochemistry, with a strong focus on understanding fish and shrimp immunological responses. His groundbreaking research on Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp and inflammation in Labeo rohita has significantly contributed to disease mitigation strategies in aquaculture. Recognized among the Top 2% of Scientists globally (Stanford/Elsevier, 2024), Dr. Kumar’s influence extends beyond research, shaping policies and fostering international collaboration.

profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Vikash Kumar’s journey into the world of aquaculture and fish health began with a strong academic foundation. With a Bachelor of Fisheries Science from the College of Fisheries, India, he excelled in his studies, earning first-class distinction with an impressive 8.66/10.0 GPA. Building upon this, he pursued a Master of Fisheries Science in Fish Health from ICAR-Central Institute of Fisheries Education (CIFE), India, where he once again showcased academic brilliance, securing an 8.23/10.0 GPA. His thirst for knowledge and dedication to research led him to Belgium, where he earned his Ph.D. from the esteemed Laboratory of Aquaculture & Artemia Reference Center, Ghent University, in 2020. Awarded with distinction, his doctoral studies solidified his expertise in fish and shrimp immunology, setting the stage for a remarkable scientific career.

🏅 Professional Endeavors

With more than 15 years of experience in aquaculture and fish health management, Dr. Kumar has made significant strides in his field. His professional journey began in 2014 as a Scientist at the ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI) in Kolkata, India. After four years of dedicated service, he embarked on his doctoral research at Ghent University, where he explored critical aspects of aquatic immunology. Returning to ICAR-CIFRI in 2020 as a Senior Scientist, he continues to contribute to the advancement of fisheries research, working with diverse stakeholders and scientists to address pressing challenges in the aquaculture industry.

🔬 Contributions and Research Focus

Dr. Kumar’s research spans a broad spectrum of critical topics in aquaculture. His expertise in transcriptomics, proteomics, cellular biology, histology, immunohistochemistry, and electron microscopy has enabled him to unravel complex immunological responses in fish and shrimp. His work has provided invaluable insights into the virulence and pathogenesis of Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp, leading to the development of innovative mitigation strategies. Additionally, his research on carrageenan-induced inflammation in Labeo rohita has contributed to a deeper understanding of fish immune responses, paving the way for improved disease management in aquaculture.

🏆 Accolades and Recognition

Dr. Kumar’s contributions to fisheries science have earned him global recognition. He is ranked among the Top 2% of Scientists worldwide as per Stanford/Elsevier rankings in 2024, a testament to his impactful research and scientific excellence. His work is widely acknowledged in the scientific community, reflecting his dedication to enhancing the health and sustainability of aquatic species. His commitment to continuous learning and innovation has made him a respected figure in fisheries research, both in India and internationally.

🌍 Impact and Influence

Dr. Kumar’s research has significantly influenced disease management strategies in aquaculture, directly benefiting the fisheries industry. His work has helped improve diagnostic methods, develop novel treatment approaches, and enhance the overall resilience of aquaculture systems against infectious diseases. His ability to collaborate with researchers worldwide has fostered the exchange of knowledge, strengthening the global scientific network dedicated to sustainable aquaculture practices.

🔬 Legacy and Future Contributions

As a dedicated scientist, Dr. Kumar’s legacy is defined by his relentless pursuit of solutions for aquaculture challenges. His research continues to inspire young scientists, and his contributions are shaping the future of fish health management. Moving forward, he aims to expand his studies on disease mitigation strategies, explore cutting-edge biotechnological approaches, and contribute to policy frameworks that promote sustainable fisheries. His unwavering commitment to scientific advancement ensures that his impact will resonate for generations to come.Dr. Vikash Kumar stands as a beacon of excellence in aquaculture research, transforming the field with his expertise, passion, and vision for a healthier aquatic future.

publication

Genus Bacillus, Promising Probiotics in Aquaculture: Aquatic Animal Origin, Bio-Active Components, Bioremediation and Efficacy in Fish and Shellfish
Authors: M Soltani, K Ghosh, SH Hoseinifar, V Kumar, AJ Lymbery, S Roy, E Ringø
Year: 2019

Application of Probiotics in Shrimp Aquaculture: Importance, Mechanisms of Action, and Methods of Administration
Authors: V Kumar, S Roy, DK Meena, UK Sarkar
Year: 2016

Acute Hepatopancreatic Necrosis Disease (AHPND): Virulence, Pathogenesis and Mitigation Strategies in Shrimp Aquaculture
Authors: V Kumar, S Roy, BK Behera, P Bossier, BK Das
Year: 2021

Immunostimulants for Aquaculture Health Management
Authors: D Barman, P Nen, SC Mandal, V Kumar
Year: 2013

A Practical Approach on SDS PAGE for Separation of Protein
Authors: S Roy, V Kumar
Year: 2014

Phloroglucinol-Mediated Hsp70 Production in Crustaceans: Protection Against Vibrio Parahaemolyticus in Artemia Franciscana and Macrobrachium Rosenbergii
Authors: V Kumar, K Baruah, DV Nguyen, G Smagghe, E Vossen, P Bossier
Year: 2018

Biofloc Microbiome with Bioremediation and Health Benefits
Authors: V Kumar, S Roy, BK Behera, BK Das
Year: 2021

Acute Phase Proteins and Their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
Authors: S Roy, V Kumar, V Kumar, BK Behera
Year: 2017

Conclusion

Dr. Vikash Kumar’s contributions to aquaculture science are both profound and far-reaching. His work not only advances scientific understanding but also provides practical solutions for the sustainable growth of the fisheries industry. His dedication to innovation, research, and global collaboration cements his status as a leading scientist in his field. As he continues his pursuit of excellence, his impact on aquatic health management will undoubtedly shape the future of sustainable aquaculture and inspire upcoming generations of researchers. 🌊🐠

Dinh Phong Son | CircRNA | Best Researcher Award

Published on 19/02/2025 by Neuroscientists

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

👩‍🎓 Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

🧪 Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

💎 Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

🌟 Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

👨‍💼 Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

Publication

Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
Year: 2025

Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
Year: 2024

Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
Authors: ChauMyThanh Tran, PhongSon Dinh
Year: 2024

Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
Year: 2023

Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
Year: 2022

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.

Baoying Huang | Pathogen Biology | Best Researcher Award

Published on 29/11/2024 by Neuroscientists

Baoying Huang | Pathogen Biology | Best Researcher Award

Ms. Baoying Huang, National Institute for Viral Disease Control and Prevention, China.

Dr. Baoying Huang, a distinguished professor at the Biotech Center for Viral Disease Emergency, China CDC, has over two decades of experience in combating viral diseases. Her expertise lies in vaccine and antiviral drug development for emerging and re-emerging infectious diseases, including COVID-19, monkeypox, and other human coronaviruses.

profile

Scopus

🎓 Education Experience

2008.09–2011.07: Doctor of Medicine, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC.2005.09–2008.07: Master of Biology, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC. 2001.09–2005.07: Bachelor of Biology,
Life Science Department, Nan Hua University, China.

👩‍🔬 Professional Experience

2020.07–Present: Professor, China CD ,Focus: Vaccine and antiviral drug R&D for SARS-CoV-2 and poxvirus diseases, including COVID-19 and monkeypox. Key Role: Participated in COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China.2015.07–2020.07: Associate Professor, China CDC. Focus: Vaccine and antiviral drug R&D for emerging infectious diseases like influenza and coronaviruses (SARS-CoV, MERS-CoV).2015.04–2015.06: Assistant Professor, China CDC. Global Health Support Program: Worked in Sierra Leone to establish Ebola lab systems, improving public health infrastructure.2011.07–2015.07: Assistant Professor, China CDC. Focus: Pathogenic molecular mechanisms of influenza viruses, pseudo-virus applications, and gene-engineered vaccines. 2005.09–2011.07: Graduate Researcher, IVDC, China CDC. Specialization: Developing universal influenza vaccines for cross-protection against various strains.

🔬 Research Focus

Baoying Huang’s work is dedicated to:Vaccine Development: COVID-19 vaccines (BBIBP-CorV, mRNA vaccines) and pan-orthopoxvirus solutions.Emerging Diseases: Countermeasures for SARS-CoV-2, monkeypox, and other viral threats.Diagnostics: Whole-genome sequencing and real-time PCR for virus detection and monitoring.Therapeutics: Screening novel antivirals targeting viruses like SARS-CoV-2 and monkeypox.Key achievements include:Leading the development of Sinopharm COVID-19 vaccine, later approved by WHO for Emergency Use Listing.Establishing monitoring systems for SARS-CoV-2 variants and assessing their impact on public health measures. Advancing monkeypox vaccine research and identifying promising antiviral compounds against orthopoxviruses.

📚 Publications

Title: Molecular architecture of monkeypox mature virus
- Authors: Hong, Y., Huang, B., Zhang, J., Tan, W., Li, S.
- Year: 2024

Title: Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression
- Authors: Wu, C., Zhang, Z., Li, Z., Deng, Y., Tan, W.
- Year: 2024

Title: A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
- Authors: Sha, Y., Huang, B., Hua, C., Tan, W., Jiang, S.
- Year: 2024

Title: Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
- Authors: Fan, Z., Xie, Y., Huang, B., Tan, W., Guo, F.
- Year: 2024

Title: Accurate determination of the whole genome sequencing and open reading frames composition of non-replicating Tiantan strain of vaccinia virus based on novel long read sequencing platform
- Authors: Zhang, Z., Wu, C., Li, H., Huang, B., Tan, W.
- Year: 2024

Title: Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
- Authors: Wu, C., Cui, L., Pan, Y., Wang, Q., Tan, W.
- Year: 2024

Title: Intranasal immunization with single-dose vaccine based on recombinant influenza virus H1N1 expressing the extracellular domain of respiratory syncytial virus G protein induces robust immunity and protection in mice
- Authors: Han, R., Wang, D., Wang, T., Huang, B., Tan, W.
- Year: 2024

Title: Rapid identification of full-length genome and tracing variations of monkeypox virus in clinical specimens based on mNGS and amplicon sequencing
- Authors: Wu, C., A, R., Ye, S., Lu, J., Tan, W.
- Year: 2024

Title: Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
- Authors: Li, M., Guo, Y., Deng, Y., Gao, G.F., Liu, J.
- Year: 2024

Title: Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays
- Authors: Huo, S., Wu, L., Huang, B., Xu, Z., Tan, W.
- Year: 2024

Conclusion

Dr. Huang’s career exemplifies unwavering dedication to improving public health through innovation in vaccine development, antiviral research, and diagnostic technologies. Her contributions to tackling global health challenges, such as the COVID-19 pandemic and monkeypox outbreaks, have significantly impacted infectious disease prevention and control worldwide. As viruses continue to evolve, her pioneering work remains a cornerstone in safeguarding global health.